Please login to the form below

Not currently logged in
Email:
Password:

Astellas appoints new US President and CEO

Astellas has appointed Seigo Kashii as president and CEO of the company's North American subsidiary

Astellas has appointed Seigo Kashii as president and CEO of the company's North American subsidiary.

Kashii's predecessor, Yoshihiko Hatanaka, will become chief strategy officer and chief financial officer at the company's Tokyo headquarters.

"Mr Kashii's outstanding leadership will further strengthen and accelerate the direction Astellas has established in our pursuit of our corporate objectives," said Yoshihiko Hatanaka. "Mr Kashii's ability to deliver results and his deep understanding of our science-driven business make him an excellent choice to continue positioning Astellas as a category leader."

Kashii has worked for Astellas for over 30 years holding positions in legal affairs, corporate planning and strategy, and also as a medical sales rep in Japan. He served as corporate executive and vice president of legal for for Astellas Pharma.

2nd April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics